 | X3K | Name: | N-[3-(1H-pyrrolo[2,3-b]pyridin-4-yl)phenyl]prop-2-enamide | Formula: | C16 H13 N3 O | SMILES: | C=CC(=O)Nc1cccc(c1)c2ccnc3[nH]ccc23 | InChi: | InChI=1S/C16H13N3O/c1-2-15(20)19-12-5-3-4-11(10-12)13-6-8-17-16-14(13)7-9-18-16/h2-10H,1H2,(H,17,18)(H,19,20) | Synonyms: | N-(3-(1h-pyrrolo[2,3-B]pyridin-4-yl)phenyl)acrylamide | Definition date: | 2023-05-31 | Last modified: | 2024-09-27 | Release date: | 2023-07-05 | Identifier: | ~{N}-[3-(1~{H}-pyrrolo[2,3-b]pyridin-4-yl)phenyl]prop-2-enamide |
|
 | 4FB | Name: | (4S)-4-FLUORO-L-PROLINE | Formula: | C5 H8 F N O2 | SMILES: | O=C(O)C1NCC(F)C1 | InChi: | InChI=1S/C5H8FNO2/c6-3-1-4(5(8)9)7-2-3/h3-4,7H,1-2H2,(H,8,9)/t3-,4-/m0/s1 | Definition date: | 2007-06-06 | Last modified: | 2024-09-27 | Identifier: | (4S)-4-fluoro-L-proline |
|
 | L9Z | Name: | (1~{S},3~{S},4~{S},5~{R})-3-(aminomethyl)-3,4,5-tris(hydroxyl)cyclohexane-1-carboxylic acid | Formula: | C8 H15 N O5 | SMILES: | NC[C]1(O)C[CH](C[CH](O)[CH]1O)C(O)=O | InChi: | InChI=1S/C8H15NO5/c9-3-8(14)2-4(7(12)13)1-5(10)6(8)11/h4-6,10-11,14H,1-3,9H2,(H,12,13)/t4-,5+,6-,8-/m0/s1 | Definition date: | 2019-08-01 | Last modified: | 2024-09-27 | Release date: | 2020-04-15 | Identifier: | (1~{S},3~{S},4~{S},5~{R})-3-(aminomethyl)-3,4,5-tris(oxidanyl)cyclohexane-1-carboxylic acid |
|
 | QZG | Name: | N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-({[trans-4-(propan-2-yl)cyclohexyl]oxy}carbonyl)-L-leucinamide | Formula: | C23 H41 N3 O5 | SMILES: | C(=O)(NC(CC(C)C)C(NC(CC1C(=O)NCC1)CO)=O)OC2CCC(CC2)C(C)C | InChi: | InChI=1S/C23H41N3O5/c1-14(2)11-20(22(29)25-18(13-27)12-17-9-10-24-21(17)28)26-23(30)31-19-7-5-16(6-8-19)15(3)4/h14-20,27H,5-13H2,1-4H3,(H,24,28)(H,25,29)(H,26,30)/t16-,17-,18-,19-,20-/m0/s1 | Definition date: | 2020-01-17 | Last modified: | 2024-09-27 | Release date: | 2020-08-12 | Identifier: | N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-({[trans-4-(propan-2-yl)cyclohexyl]oxy}carbonyl)-L-leucinamide |
|
 | Y91 | Name: | (1S,2S)-2-((S)-2-(((((1R,3r,5S)-bicyclo[3.3.1]nonan-3-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | Formula: | C24 H41 N3 O8 S | SMILES: | CC(C)C[CH](NC(=O)OC[CH]1C[CH]2CCC[CH](C2)C1)C(=O)N[CH](C[CH]3CCNC3=O)[CH](O)[S](O)(=O)=O | InChi: | InChI=1S/C24H41N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h14-20,23,30H,3-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17+,18-,19-,20-,23-/m0/s1 | Definition date: | 2021-02-10 | Last modified: | 2024-09-27 | Release date: | 2021-02-17 | Identifier: | (2~{S})-2-[[(2~{S})-2-[[(1~{R},5~{S})-3-bicyclo[3.3.1]nonanyl]methoxycarbonylamino]-4-methyl-pentanoyl]amino]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | SZR | Name: | (2R)-4-cyano-2-hydroxybutanoic acid | Formula: | C5 H7 N O3 | SMILES: | O=C(O)C(O)CCC#N | InChi: | InChI=1S/C5H7NO3/c6-3-1-2-4(7)5(8)9/h4,7H,1-2H2,(H,8,9)/t4-/m1/s1 | Definition date: | 2022-07-13 | Last modified: | 2024-09-27 | Release date: | 2023-05-24 | Identifier: | (2R)-4-cyano-2-hydroxybutanoic acid |
|
 | NAU | Name: | 4,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDONONANOIC ACID | Formula: | C11 H21 N O9 | SMILES: | O=C(NC(C(O)(O)CCC(=O)O)C(O)C(O)C(O)CO)C | InChi: | InChI=1S/C11H21NO9/c1-5(14)12-10(9(19)8(18)6(15)4-13)11(20,21)3-2-7(16)17/h6,8-10,13,15,18-21H,2-4H2,1H3,(H,12,14)(H,16,17)/t6-,8-,9+,10+/m1/s1 | Definition date: | 2000-07-14 | Last modified: | 2024-09-27 | Identifier: | (5S,6R,7S,8R)-5-(acetylamino)-4,4,6,7,8,9-hexahydroxynonanoic acid (non-preferred name) |
|
 | NAV | Name: | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO-4-OXONONANOIC ACID | Formula: | C11 H19 N O8 | SMILES: | O=C(O)CCC(=O)C(NC(=O)C)C(O)C(O)C(O)CO | InChi: | InChI=1S/C11H19NO8/c1-5(14)12-9(6(15)2-3-8(17)18)11(20)10(19)7(16)4-13/h7,9-11,13,16,19-20H,2-4H2,1H3,(H,12,14)(H,17,18)/t7-,9-,10-,11-/m1/s1 | Definition date: | 2000-07-17 | Last modified: | 2024-09-27 | Identifier: | 5-(acetylamino)-2,3,5-trideoxy-D-manno-non-4-ulosonic acid |
|
 | S6F | Name: | ~{N}-[(2~{S})-1-(2-chlorophenyl)-3-oxidanylidene-propan-2-yl]ethanamide | Formula: | C11 H12 Cl N O2 | SMILES: | CC(=O)N[CH](Cc1ccccc1Cl)C=O | InChi: | InChI=1S/C11H12ClNO2/c1-8(15)13-10(7-14)6-9-4-2-3-5-11(9)12/h2-5,7,10H,6H2,1H3,(H,13,15)/t10-/m0/s1 | Definition date: | 2022-12-13 | Last modified: | 2024-09-27 | Release date: | 2022-12-21 | Identifier: | ~{N}-[(2~{S})-1-(2-chlorophenyl)-3-oxidanylidene-propan-2-yl]ethanamide |
|
 | YMA | Name: | 7,10,13-TRI(CARBOXYMETHYL)-5,15-DIOXO-4,7,10,13,16-PENTAAZA-1,19-DITHIANONADECANE | Formula: | C18 H33 N5 O8 S2 | SMILES: | O=C(NCCS)CN(CCN(CC(=O)O)CCN(CC(=O)NCCS)CC(=O)O)CC(=O)O | InChi: | InChI=1S/C18H33N5O8S2/c24-14(19-1-7-32)9-22(12-17(28)29)5-3-21(11-16(26)27)4-6-23(13-18(30)31)10-15(25)20-2-8-33/h32-33H,1-13H2,(H,19,24)(H,20,25)(H,26,27)(H,28,29)(H,30,31) | Definition date: | 2004-10-14 | Last modified: | 2024-09-27 | Identifier: | N,N-bis{2-[(carboxymethyl){2-oxo-2-[(2-sulfanylethyl)amino]ethyl}amino]ethyl}glycine |
|
 | PRF | Name: | 7-DEAZA-7-AMINOMETHYL-GUANINE | Formula: | C7 H9 N5 O | SMILES: | O=C1c2c(cnc2N=C(N1)N)CN | InChi: | InChI=1S/C7H9N5O/c8-1-3-2-10-5-4(3)6(13)12-7(9)11-5/h2H,1,8H2,(H4,9,10,11,12,13) | Definition date: | 2000-02-14 | Last modified: | 2024-09-27 | Identifier: | 2-amino-5-(aminomethyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one |
|
 | NOU | Name: | (2S)-2-amino-4-[(pyridin-2-yl)amino]butanoic acid | Formula: | C9 H13 N3 O2 | SMILES: | O=C(O)C(N)CCNc1ccccn1 | InChi: | InChI=1S/C9H13N3O2/c10-7(9(13)14)4-6-12-8-3-1-2-5-11-8/h1-3,5,7H,4,6,10H2,(H,11,12)(H,13,14)/t7-/m0/s1 | Definition date: | 2022-04-07 | Last modified: | 2024-09-27 | Release date: | 2023-08-30 | Identifier: | (2S)-2-amino-4-[(pyridin-2-yl)amino]butanoic acid |
|
 | UZ1 | Name: | cyclopropanamine | Formula: | C3 H7 N | SMILES: | NC1CC1 | InChi: | InChI=1S/C3H7N/c4-3-1-2-3/h3H,1-2,4H2 | Definition date: | 2020-06-08 | Last modified: | 2024-09-27 | Release date: | 2020-06-17 | Identifier: | cyclopropanamine |
|
 | LA2 | Name: | N~6~-[(6R)-6,8-disulfanyloctanoyl]-L-lysine | Formula: | C14 H28 N2 O3 S2 | SMILES: | O=C(O)C(N)CCCCNC(=O)CCCCC(S)CCS | InChi: | InChI=1S/C14H28N2O3S2/c15-12(14(18)19)6-3-4-9-16-13(17)7-2-1-5-11(21)8-10-20/h11-12,20-21H,1-10,15H2,(H,16,17)(H,18,19)/t11-,12+/m1/s1 | Synonyms: | lipoyllysine | Definition date: | 2008-04-16 | Last modified: | 2024-09-27 | Identifier: | N~6~-[(6R)-6,8-disulfanyloctanoyl]-L-lysine |
|
 | NOW | Name: | Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2Z)-2-iminoethyl]-3-methyl-L-phenylalaninamide | Formula: | C21 H29 N5 O2 | SMILES: | O=C(c1cc(nn1C)C(C)(C)C)NC(C(=O)NCC=[N@H])Cc2cccc(c2)C | InChi: | InChI=1S/C21H29N5O2/c1-14-7-6-8-15(11-14)12-16(19(27)23-10-9-22)24-20(28)17-13-18(21(2,3)4)25-26(17)5/h6-9,11,13,16,22H,10,12H2,1-5H3,(H,23,27)(H,24,28)/b22-9+/t16-/m0/s1 | Definition date: | 2009-05-22 | Last modified: | 2024-09-27 | Identifier: | Nalpha-[(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)carbonyl]-N-[(2Z)-2-iminoethyl]-3-methyl-L-phenylalaninamide |
|
 | QL9 | Name: | 3-bromanyl-4-methanoyl-~{N}-methyl-~{N}-(2-sulfanylethyl)benzamide | Formula: | C11 H12 Br N O2 S | SMILES: | CN(CCS)C(=O)c1ccc(C=O)c(Br)c1 | InChi: | InChI=1S/C11H12BrNO2S/c1-13(4-5-16)11(15)8-2-3-9(7-14)10(12)6-8/h2-3,6-7,16H,4-5H2,1H3 | Definition date: | 2022-11-08 | Last modified: | 2024-09-27 | Release date: | 2023-03-29 | Identifier: | 3-bromanyl-4-methanoyl-~{N}-methyl-~{N}-(2-sulfanylethyl)benzamide |
|
 | QZJ | Name: | N~2~-{[(trans-4-ethylcyclohexyl)oxy]carbonyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C22 H39 N3 O5 | SMILES: | C(CC1C(=O)NCC1)(NC(C(CC(C)C)NC(=O)OC2CCC(CC2)CC)=O)CO | InChi: | InChI=1S/C22H39N3O5/c1-4-15-5-7-18(8-6-15)30-22(29)25-19(11-14(2)3)21(28)24-17(13-26)12-16-9-10-23-20(16)27/h14-19,26H,4-13H2,1-3H3,(H,23,27)(H,24,28)(H,25,29)/t15-,16-,17-,18-,19-/m0/s1 | Definition date: | 2020-01-17 | Last modified: | 2024-09-27 | Release date: | 2020-08-12 | Identifier: | N~2~-{[(trans-4-ethylcyclohexyl)oxy]carbonyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
 | PRJ | Name: | (2S,3aS,6R,7aS)-6-hydroxyoctahydro-1H-indole-2-carboxylic acid | Formula: | C9 H15 N O3 | SMILES: | O=C(O)C1NC2CC(O)CCC2C1 | InChi: | InChI=1S/C9H15NO3/c11-6-2-1-5-3-8(9(12)13)10-7(5)4-6/h5-8,10-11H,1-4H2,(H,12,13)/t5-,6+,7-,8-/m0/s1 | Definition date: | 2010-11-05 | Last modified: | 2024-09-27 | Identifier: | (2S,3aS,6R,7aS)-6-hydroxyoctahydro-1H-indole-2-carboxylic acid |
|
 | YMD | Name: | (1R,2S)-2-((S)-2-((((4,4-dimethylcyclohexyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | Formula: | C22 H39 N3 O8 S | SMILES: | CC(C)CC(NC(=O)OC1CCC(C)(C)CC1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C22H39N3O8S/c1-13(2)11-16(25-21(29)33-15-5-8-22(3,4)9-6-15)19(27)24-17(20(28)34(30,31)32)12-14-7-10-23-18(14)26/h13-17,20,28H,5-12H2,1-4H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t14-,16-,17-,20+/m0/s1 | Definition date: | 2021-03-12 | Last modified: | 2024-09-27 | Release date: | 2021-03-24 | Identifier: | (1R,2S)-2-[(N-{[(4,4-dimethylcyclohexyl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | A1A7S | Name: | S-{2-[(N-{(2R)-2-hydroxy-3,3-dimethyl-4-[(trihydroxy-lambda~5~-phosphanyl)oxy]butanoyl}-beta-alanyl)amino]ethyl} 2-hydroxybenzene-1-carbothioate | Formula: | C18 H27 N2 O9 P S | SMILES: | Oc1ccccc1C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)O | InChi: | InChI=1S/C18H27N2O9PS/c1-18(2,11-29-30(26,27)28)15(23)16(24)20-8-7-14(22)19-9-10-31-17(25)12-5-3-4-6-13(12)21/h3-6,15,21,23H,7-11H2,1-2H3,(H,19,22)(H,20,24)(H2,26,27,28)/t15-/m0/s1 | Definition date: | 2024-09-17 | Last modified: | 2024-09-27 | Release date: | 2024-09-25 | Identifier: | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] 2-hydroxybenzene-1-carbothioate |
|
 | UZ4 | Name: | (2R,3S)-3-amino-2-hydroxy-4-[(3S)-2-oxopyrrolidin-3-yl]butanoic acid | Formula: | C8 H14 N2 O4 | SMILES: | NC(C(O)C(O)=O)CC1CCNC1=O | InChi: | InChI=1S/C8H14N2O4/c9-5(6(11)8(13)14)3-4-1-2-10-7(4)12/h4-6,11H,1-3,9H2,(H,10,12)(H,13,14)/t4-,5-,6+/m0/s1 | Definition date: | 2020-06-08 | Last modified: | 2024-09-27 | Release date: | 2020-06-17 | Identifier: | (2R,3S)-3-amino-2-hydroxy-4-[(3S)-2-oxopyrrolidin-3-yl]butanoic acid |
|
 | PRK | Name: | N~6~-propanoyl-L-lysine | Formula: | C9 H18 N2 O3 | SMILES: | O=C(O)C(N)CCCCNC(=O)CC | InChi: | InChI=1S/C9H18N2O3/c1-2-8(12)11-6-4-3-5-7(10)9(13)14/h7H,2-6,10H2,1H3,(H,11,12)(H,13,14)/t7-/m0/s1 | Synonyms: | N(6)-Propionyllysine | Definition date: | 2010-05-12 | Last modified: | 2024-09-27 | Identifier: | N~6~-propanoyl-L-lysine |
|
 | RRV | Name: | (2R)-2,4-dihydroxy-N-[(3S)-3-hydroxy-4-phenylbutyl]-3,3-dimethylbutanamide | Formula: | C16 H25 N O4 | SMILES: | O=C(NCCC(O)Cc1ccccc1)C(O)C(C)(C)CO | InChi: | InChI=1S/C16H25NO4/c1-16(2,11-18)14(20)15(21)17-9-8-13(19)10-12-6-4-3-5-7-12/h3-7,13-14,18-20H,8-11H2,1-2H3,(H,17,21)/t13-,14+/m1/s1 | Definition date: | 2014-04-11 | Last modified: | 2024-09-27 | Release date: | 2014-12-10 | Identifier: | (2R)-2,4-dihydroxy-N-[(3S)-3-hydroxy-4-phenylbutyl]-3,3-dimethylbutanamide |
|
 | KH0 | Name: | ~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{S})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate | Formula: | C31 H41 N5 O7 | SMILES: | CC(C)(C)OC(=O)NC1=CC=CN([CH](CC2CC2)C(=O)N[CH](C[CH]3CCNC3=O)[CH](O)C(=O)NCc4ccccc4)C1=O | InChi: | InChI=1S/C31H41N5O7/c1-31(2,3)43-30(42)35-22-10-7-15-36(29(22)41)24(16-19-11-12-19)27(39)34-23(17-21-13-14-32-26(21)38)25(37)28(40)33-18-20-8-5-4-6-9-20/h4-10,15,19,21,23-25,37H,11-14,16-18H2,1-3H3,(H,32,38)(H,33,40)(H,34,39)(H,35,42)/t21-,23-,24-,25-/m0/s1 | Synonyms: | (S,S,S)-13b | Definition date: | 2023-08-14 | Last modified: | 2024-09-27 | Release date: | 2023-08-23 | Identifier: | ~{tert}-butyl ~{N}-[1-[(2~{S})-3-cyclopropyl-1-oxidanylidene-1-[[(2~{S},3~{S})-3-oxidanyl-4-oxidanylidene-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]-4-[(phenylmethyl)amino]butan-2-yl]amino]propan-2-yl]-2-oxidanylidene-pyridin-3-yl]carbamate |
|
 | YMG | Name: | (1S,2S)-2-((S)-2-((((4,4-dimethylcyclohexyl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | Formula: | C22 H39 N3 O8 S | SMILES: | CC(C)CC(NC(=O)OC1CCC(C)(C)CC1)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C22H39N3O8S/c1-13(2)11-16(25-21(29)33-15-5-8-22(3,4)9-6-15)19(27)24-17(20(28)34(30,31)32)12-14-7-10-23-18(14)26/h13-17,20,28H,5-12H2,1-4H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t14-,16-,17-,20-/m0/s1 | Definition date: | 2021-03-12 | Last modified: | 2024-09-27 | Release date: | 2021-03-24 | Identifier: | (1S,2S)-2-[(N-{[(4,4-dimethylcyclohexyl)oxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|